5 Lung Cancer Clinical Trials in Huntsville, NC (2026)

Q: How do I join a clinical trial in Huntsville?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Huntsville research site will contact you.

Recruiting Lung Cancer Studies in Huntsville

NCT06119581Recruiting

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

The purpose of this study is to assess if adding LY3537982 (olomorasib) in combination with standard of care anti-cancer drugs is more effective than standard of care in participants with untreated ad...

Huntsville, NC1,264 participantsEli Lilly and Company

View Study Details

NCT06890598Recruiting

Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer

The main purpose of this study is to assess if olomorasib in combination with pembrolizumab is more effective than the pembrolizumab and placebo combination in part A in participants with resected KRA...

Huntsville, NC700 participantsEli Lilly and Company

View Study Details

NCT06667076Recruiting

A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

The primary purpose of the study is to assess how well amivantamab in combination with lazertinib or in combination with chemotherapy works (antitumor activity) in participants with epidermal growth f...

Huntsville, NC480 participantsJanssen Research & Development, LLC

View Study Details

NCT07080242Recruiting

Evaluating BL-M14D1 in Subjects With Locally Advanced or Metastatic Small Cell Lung Cancer and Neuroendocrine Tumors

The objective of this study is to evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of BL-M14D1 in Subjects with locally Advanced or Metastatic Small Cell Lung Cancer and Other Neuroen...

Huntsville, NC120 participantsSystImmune Inc.

View Study Details

NCT05271292Recruiting

Chiauranib for Advanced Solid Malignant Tumors and Relapsed/Refractory SCLC.

This is a Phase 1b/2, single-arm, open-label, dose-escalation study including 2 stages: Phase 1b: Dose-Escalation Stage (Single-Dose and Consecutive-Dose Periods) Phase 2: recommended Phase 2 dose (...

Huntsville, NC36 participantsChipscreen Biosciences, Ltd.

View Study Details

About Lung Cancer Clinical Trials in Huntsville

Lung cancer is the leading cause of cancer death worldwide, starting in the cells of the lungs. The two main types are non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC). Treatments include surgery, chemotherapy, radiation, immunotherapy, and targeted drugs.

There are currently 5 lung cancer clinical trials recruiting participants in Huntsville, NC. These studies are seeking a combined 2,600 participants. Research is being sponsored by Eli Lilly and Company, Janssen Research & Development, LLC, SystImmune Inc. and 1 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Lung Cancer Clinical Trials in Huntsville — FAQ

Are there lung cancer clinical trials in Huntsville?

Yes, there are 5 lung cancer clinical trials currently recruiting in Huntsville, NC. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Huntsville?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Huntsville research site will contact you about next steps.

Are clinical trials in Huntsville free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Huntsville studies also compensate for your time and travel.

What lung cancer treatments are being tested?

The 5 active trials in Huntsville are testing new therapies including novel drugs, biologics, and treatment approaches for lung cancer.

Data updated July 13, 2026 from ClinicalTrials.gov